Preclinical evaluation of a novel antibody-drug conjugate OBI-992 for Cancer therapy.
新型抗体药物偶联物 OBI-992 用于癌症治疗的临床前评价
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-92697-z
Chang Ting-Yu, Lin Chun-Jung, Wen Shih-Ni, Wu Yi-Chen, Wei Cheng-Yen, Huang Jye-Yu, Tsao Yu-Hsuan, Chen Yu-Jung, Tang Wei-Chien, Wu Yuen-Chin, Lee Wei-Han, Huang Teng-Yi, Kuo Tzer-Min, Li Wan-Fen, Lai Ming-Tain